Summary of Study ST003150
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001958. The data can be accessed directly via it's Project DOI: 10.21228/M8MX5P This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003150 |
Study Title | Impact of early-life exposure to a potent aryl hydrocarbon receptor ligand on gut microbiota and host glucose homeostasis in C57BL/6J male mice (Part II) |
Study Summary | This study aimed to explore the association between early-life exposure to a potent aryl hydrocarbon receptor (AHR) agonist and persistent disruptions in the microbiota, leading to impaired metabolic homeostasis later in life. This study utilized metagenomics, NMR- and mass spectrometry-based metabolomics, and biochemical assays to analyze the gut microbiome composition and function, as well as the physiological and metabolic effects of early-life exposure to 2,3,7,8-tetrachlorodibenzofuran (TCDF) in conventional, germ-free (GF), and Ahr-null mice. The impact of TCDF on Akkermansia muciniphila (A. muciniphila) in vitro was assessed using optical density (OD 600), flow cytometry, transcriptomics, and mass spectrometry-based metabolomics. TCDF-exposed mice exhibited disruption in the gut microbiome community structure and function, characterized by lower abundances of A. muciniphila, lower levels of cecal short chain fatty acids (SCFAs) and indole-3-lactic acid (ILA), and a reduction in gut hormones GLP-1 and PYY. Importantly, microbial and metabolic phenotypes associated with early-life POP exposure were transferable to GF recipients in the absence of POP carry-over. In addition, AHR-independent interactions between POPs and the microbiota were observed, significantly affected the growth, physiology, gene expression, and metabolic activity of A. muciniphila, resulting in suppressed activity along the ILA pathway. |
Institute | Pennsylvania State University |
Department | Department of Veterinary and Biomedical Sciences |
Last Name | Koo |
First Name | Imhoi |
Address | 307B Life Science Building |
iuk41@psu.edu | |
Phone | +1 814-865-7803 |
Submit Date | 2024-03-28 |
Raw Data Available | Yes |
Raw Data File Type(s) | cdf |
Analysis Type Detail | GC-MS |
Release Date | 2024-04-30 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001958 |
Project DOI: | doi: 10.21228/M8MX5P |
Project Title: | Impact of early-life exposure to a potent aryl hydrocarbon receptor ligand on gut microbiota and host glucose homeostasis in C57BL/6J male mice |
Project Summary: | This study aimed to explore the association between early-life exposure to a potent aryl hydrocarbon receptor (AHR) agonist and persistent disruptions in the microbiota, leading to impaired metabolic homeostasis later in life. This study utilized metagenomics, NMR- and mass spectrometry-based metabolomics, and biochemical assays to analyze the gut microbiome composition and function, as well as the physiological and metabolic effects of early-life exposure to 2,3,7,8-tetrachlorodibenzofuran (TCDF) in conventional, germ-free (GF), and Ahr-null mice. The impact of TCDF on Akkermansia muciniphila (A. muciniphila) in vitro was assessed using optical density (OD 600), flow cytometry, transcriptomics, and mass spectrometry-based metabolomics. TCDF-exposed mice exhibited disruption in the gut microbiome community structure and function, characterized by lower abundances of A. muciniphila, lower levels of cecal short chain fatty acids (SCFAs) and indole-3-lactic acid (ILA), and a reduction in gut hormones GLP-1 and PYY. Importantly, microbial and metabolic phenotypes associated with early-life POP exposure were transferable to GF recipients in the absence of POP carry-over. In addition, AHR-independent interactions between POPs and the microbiota were observed, significantly affected the growth, physiology, gene expression, and metabolic activity of A. muciniphila, resulting in suppressed activity along the ILA pathway. |
Institute: | Pennsylvania State University |
Department: | Department of Veterinary and Biomedical Sciences |
Last Name: | Koo |
First Name: | Imhoi |
Address: | 307B Life Science Building |
Email: | iuk41@psu.edu |
Phone: | +1 814-865-7803 |
Subject:
Subject ID: | SU003267 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Age Or Age Range: | 4 weeks to 5 months |
Gender: | Male |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample source | Treatment |
---|---|---|---|
SA340917 | YT201026_14 | liver | TCDF |
SA340918 | YT201026_15 | liver | TCDF |
SA340919 | YT201026_16 | liver | TCDF |
SA340920 | YT200819_110 | liver | TCDF |
SA340921 | YT200819_109 | liver | TCDF |
SA340922 | YT200819_107 | liver | TCDF |
SA340923 | YT200819_108 | liver | TCDF |
SA340924 | YT201026_17 | liver | TCDF |
SA340925 | YT201026_19 | liver | TCDF |
SA340926 | YT210427_19 | liver | TCDF |
SA340927 | YT210427_20 | liver | TCDF |
SA340928 | YT210427_21 | liver | TCDF |
SA340929 | YT210427_18 | liver | TCDF |
SA340930 | YT210427_17 | liver | TCDF |
SA340931 | YT200819_106 | liver | TCDF |
SA340932 | YT210427_16 | liver | TCDF |
SA340933 | YT201026_18 | liver | TCDF |
SA340934 | YT200819_105 | liver | TCDF |
SA340935 | YT200819_11 | liver | TCDF |
SA340936 | YT200819_10 | liver | TCDF |
SA340937 | YT200819_09 | liver | TCDF |
SA340938 | YT200819_08 | liver | TCDF |
SA340939 | YT200819_13 | liver | TCDF |
SA340940 | YT200819_12 | liver | TCDF |
SA340941 | YT200819_06 | liver | vehicle |
SA340942 | YT200819_07 | liver | vehicle |
SA340943 | YT200819_05 | liver | vehicle |
SA340944 | YT200819_04 | liver | vehicle |
SA340945 | YT200819_03 | liver | vehicle |
SA340946 | YT200819_104 | liver | vehicle |
SA340947 | YT200819_103 | liver | vehicle |
SA340948 | YT200819_22 | liver | vehicle |
SA340949 | YT200819_02 | liver | vehicle |
SA340950 | YT200819_101 | liver | vehicle |
SA340951 | YT200819_102 | liver | vehicle |
SA340952 | YT200819_21 | liver | vehicle |
Showing results 1 to 36 of 36 |
Collection:
Collection ID: | CO003260 |
Collection Summary: | Liver tissue samples were collected immediately after sacrifice by carbon dioxide asphyxiation and kept at -80°C. |
Sample Type: | Liver |
Treatment:
Treatment ID: | TR003276 |
Treatment Summary: | 1. After feed training, mice were fed pills containing TCDF (dissolved in acetone) or acetone alone as vehicle, and one pill uniformly contained 0.46 µg TCDF (24 µg/kg as final dose). Mice were housed singly in an empty cage and monitored to ensure the pill was consumed in the morning for 5 days. 2. TCDF (24 µg/kg) or corn oil as vehicle were administered to age-matched male GF and Ahr-/- mice by oral gavage once daily for five days (n = 4 per group). 3. Four-week-old male GF C57BL/6J mice were orally gavaged with 100 µL of cecal suspension (100 mg in 1 mL sterile BHI CHV media) from vehicle or TCDF treated mice in long-duration model. 4. A. muciniphila was administered to GF mice by oral gavage at one dose 107 CFU/0.1 mL suspended in sterile BHI CHV media containing an end concentration of glycerol (15% vol/vol). |
Sample Preparation:
Sampleprep ID: | SP003274 |
Sampleprep Summary: | For liver lipid quantification, 50 mg of liver tissue was homogenized in 1 mL pre-cooled chloroform/methanol mix [1:1 (v/v)], followed by adding 296 µL water. After centrifugation (10,000 g, 4°C) for 10 min, the lower phase was dried in a vacuum and reconstituted in 600 µL of deuterated chloroform containing 0.03% (v/v) tetramethylsilane (TMS). |
Sampleprep Protocol Filename: | PSU_Methyl_esterification_GCMS_032724.pdf |
Combined analysis:
Analysis ID | AN005168 |
---|---|
Analysis type | MS |
Chromatography type | GC |
Chromatography system | Agilent 7890A |
Column | Restek Rtx-5Sil MS (30m x 0.25mm, 0.25um) |
MS Type | EI |
MS instrument type | Single quadrupole |
MS instrument name | Agilent 5975C |
Ion Mode | POSITIVE |
Units | peak area |
Chromatography:
Chromatography ID: | CH003910 |
Instrument Name: | Agilent 7890A |
Column Name: | Restek Rtx-5Sil MS (30m x 0.25mm, 0.25um) |
Column Temperature: | 325 |
Flow Gradient: | N/A |
Flow Rate: | 0.5658 mL/min |
Solvent A: | N/A |
Solvent B: | N/A |
Chromatography Type: | GC |
MS:
MS ID: | MS004903 |
Analysis ID: | AN005168 |
Instrument Name: | Agilent 5975C |
Instrument Type: | Single quadrupole |
MS Type: | EI |
MS Comments: | For ionization, the EI source was used with the following settings: filament source temperature at 230 °C and electron ionization energy at 70 eV. Mass spectra were collected in a mass range of m/z 50 - 600 at a scan rate of 2 spectra/s. Mass calibration was performed after every injection with internal reference masses m/z 68.9947, 263.9866 and 501.9706. Data acquisition was performed using the Agilent MassHunter Workstation GC-MS Data Acquisition v 10.0 (Agilent Technologies, Waldbronn, Germany). |
Ion Mode: | POSITIVE |
Analysis Protocol File: | PSU_tissue_POP_measurement_GCMS_032724.pdf |